Literature DB >> 16277503

Total synthesis of piericidin A1 and B1.

Martin J Schnermann1, Dale L Boger.   

Abstract

The first total syntheses of piericidin A1 and B1 are disclosed and unambiguously establish the relative and absolute stereochemistry of the natural products by an approach that will facilitate the synthesis of a series of analogues. Central to the approach is an inverse electron demand Diels-Alder reaction of a N-sulfonyl-1-aza-1,3-butadiene with tetramethoxyethene followed by Lewis acid-promoted aromatization used to assemble the functionalized pyridine core. Additional key elements in the convergent approach include the use of an anti-aldol reaction to install the C9 and C10 relative and absolute stereochemistry, a modified Julia olefination for formation of the C5-C6 trans double bond with convergent assemblage of the side chain, and a penultimate heterobenzylic Stille cross-coupling reaction of the pyridyl core with the fully elaborated side chain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16277503      PMCID: PMC2504520          DOI: 10.1021/ja055041f

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  10 in total

1.  STRUCTURE OF PIERCIDIN A.

Authors:  N TAKAHASHI; A SUZUKI; S TAMURA
Journal:  J Am Chem Soc       Date:  1965-05-05       Impact factor: 15.419

2.  Kulokekahilide-2, a cytotoxic depsipeptide from a cephalaspidean mollusk Philinopsis speciosa.

Authors:  Yoichi Nakao; Wesley Y Yoshida; Yuuki Takada; Junji Kimura; Liu Yang; Susan L Mooberry; Paul J Scheuer
Journal:  J Nat Prod       Date:  2004-08       Impact factor: 4.050

3.  Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH:ubiquinone oxidoreductase).

Authors:  J G Okun; P Lümmen; U Brandt
Journal:  J Biol Chem       Date:  1999-01-29       Impact factor: 5.157

Review 4.  Inhibitors of NADH-ubiquinone reductase: an overview.

Authors:  M Degli Esposti
Journal:  Biochim Biophys Acta       Date:  1998-05-06

5.  IT-143-A and B, novel piericidin-group antibiotics produced by Streptomyces sp.

Authors:  A Urakawa; T Sasaki; K Yoshida; T Otani; Y Lei; W Yun
Journal:  J Antibiot (Tokyo)       Date:  1996-10       Impact factor: 2.649

6.  Total synthesis of the microtubule stabilizing antitumor agent laulimalide and some nonnatural analogues: the power of Sharpless' asymmetric epoxidation.

Authors:  Anjum Ahmed; E Kate Hoegenauer; Valentin S Enev; Martin Hanbauer; Hanspeter Kaehlig; Elisabeth Ohler; Johann Mulzer
Journal:  J Org Chem       Date:  2003-04-18       Impact factor: 4.354

7.  Pd/P(t-Bu)(3): a mild and general catalyst for Stille reactions of aryl chlorides and aryl bromides.

Authors:  Adam F Littke; Lothar Schwarz; Gregory C Fu
Journal:  J Am Chem Soc       Date:  2002-06-05       Impact factor: 15.419

8.  Two binding sites of inhibitors in NADH: ubiquinone oxidoreductase (complex I). Relationship of one site with the ubiquinone-binding site of bacterial glucose:ubiquinone oxidoreductase.

Authors:  T Friedrich; P van Heek; H Leif; T Ohnishi; E Forche; B Kunze; R Jansen; W Trowitzsch-Kienast; G Höfle; H Reichenbach
Journal:  Eur J Biochem       Date:  1994-01-15

9.  Structure of piericidin B and stereochemistry of piericidins.

Authors:  N Takahashi; A Suzuki; Y Kimura; S Miyamoto
Journal:  Tetrahedron Lett       Date:  1967-05       Impact factor: 2.415

10.  Polyprenylpyridinols. Synthesis of piericidin analogues.

Authors:  F P Schmidtchen; H Rapoport
Journal:  J Am Chem Soc       Date:  1977-10-12       Impact factor: 15.419

  10 in total
  12 in total

1.  Total synthesis of piericidin A1 and B1 and key analogues.

Authors:  Martin J Schnermann; F Anthony Romero; Inkyu Hwang; Eiko Nakamaru-Ogiso; Takao Yagi; Dale L Boger
Journal:  J Am Chem Soc       Date:  2006-09-13       Impact factor: 15.419

2.  Cycloadditions of 1,2,3-Triazines Bearing C5-Electron Donating Substituents: Robust Pyrimidine Synthesis.

Authors:  Christopher M Glinkerman; Dale L Boger
Journal:  Org Lett       Date:  2015-07-14       Impact factor: 6.005

3.  Inverse electron demand Diels-Alder reactions of 1,2,3-triazines: pronounced substituent effects on reactivity and cycloaddition scope.

Authors:  Erin D Anderson; Dale L Boger
Journal:  J Am Chem Soc       Date:  2011-07-19       Impact factor: 15.419

4.  Scope of the inverse electron demand Diels-Alder reactions of 1,2,3-triazine.

Authors:  Erin D Anderson; Dale L Boger
Journal:  Org Lett       Date:  2011-04-13       Impact factor: 6.005

5.  Stereospecific cross-coupling of alpha-(thiocarbamoyl)organostannanes with alkenyl, aryl, and heteroaryl iodides.

Authors:  J R Falck; Paresh K Patel; Anish Bandyopadhyay
Journal:  J Am Chem Soc       Date:  2007-01-31       Impact factor: 15.419

Review 6.  The unique chemistry and biology of the piericidins.

Authors:  Xuefeng Zhou; William Fenical
Journal:  J Antibiot (Tokyo)       Date:  2016-06-15       Impact factor: 2.649

7.  Direct Synthesis of β-Aminoenals through Reaction of 1,2,3-Triazine with Secondary Amines.

Authors:  Ryan E Quiñones; Christopher M Glinkerman; Kaicheng Zhu; Dale L Boger
Journal:  Org Lett       Date:  2017-06-28       Impact factor: 6.005

8.  An NF-κB-based high-throughput screen identifies piericidins as inhibitors of the Yersinia pseudotuberculosis type III secretion system.

Authors:  Miles C Duncan; Weng Ruh Wong; Allison J Dupzyk; Walter M Bray; Roger G Linington; Victoria Auerbuch
Journal:  Antimicrob Agents Chemother       Date:  2013-12-02       Impact factor: 5.191

9.  Diastereoselective Diels-Alder reactions of N-sulfonyl-1-aza-1,3-butadienes with optically active enol ethers: an asymmetric variant of the 1-azadiene Diels-Alder reaction.

Authors:  Ryan C Clark; Steven S Pfeiffer; Dale L Boger
Journal:  J Am Chem Soc       Date:  2006-03-01       Impact factor: 15.419

10.  Total synthesis of piericidin A1. Application of a modified Negishi carboalumination-nickel-catalyzed cross-coupling.

Authors:  Bruce H Lipshutz; Benjamin Amorelli
Journal:  J Am Chem Soc       Date:  2009-02-04       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.